Barinthus Biotherapeutics plc. cotiza a 0.74 USD y tiene una capitalización bursátil de $30M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Barinthus Biotherapeutics plc, together with its subsidiaries, engages in the research, development, and commercialization of immunotherapies and vaccines in the United States and the United Kingdom. The company develops VTP-1000, an antigen-specific immune tolerance candidate, which is in Phase I clinical trial to res…
| Periodo | 2025-08 |
|---|---|
| Real | — |
| Estimado | $-0.33 |
| Sorpresa | — |
| Métrica | BRNS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -89.5% | -40.4% | -49.1% |
| ROA | -67.7% | -32.0% | -35.7% |
| Current Ratio | 7.77 | 2.84 | +4.93 |
| Debt / Equity | — | 0.28 | — |